Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
24
Number of overlapping holdings
20.3%
% of XBI's 119 holdings also in PBE
85.7%
% of PBE's 28 holdings also in XBI
Overlap by Weight
Sector Drift (XBI minus PBE)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in XBI |
Weight in PBE |
Overlap | |
|---|---|---|---|---|
 |
NATERA INC | 2.8% | 5.4% | 2.8% |
|
NEUROCRINE BIOSCIENCES INC | 2.6% | 4.9% | 2.6% |
|
UNITED THERAPEUTICS CORP | 2.6% | 4.5% | 2.6% |
|
GILEAD SCIENCES INC | 2.5% | 5.3% | 2.5% |
|
EXACT SCIENCES CORP | 2.5% | 2.5% | 2.5% |
Position Highlights (Non-Overlapping Exposures)
XBI Overweight Relative to PBE
|
VERTEX PHARMACEUTICALS INC | 2.7% |
|
INSMED INC | 2.7% |
|
ALNYLAM PHARMACEUTICALS INC | 2.7% |
|
MADRIGAL PHARMACEUTICALS, INC. | 2.3% |
|
ABBVIE INC | 2.3% |
|
MODERNA, INC. | 2.0% |
|
BRIDGEBIO PHARMA, INC. | 1.8% |
|
REVOLUTION MEDICINES, INC. | 1.5% |
|
CYTOKINETICS INC | 1.5% |
|
SUMMIT THERAPEUTICS INC | 1.4% |
XBI Underweight Relative to PBE
|
ILLUMINA INC | -4.2% |
|
PROTAGONIST THERAPEUTICS, INC. | -3.5% |
|
ROYALTY PHARMA PLC CLASS A | -3.0% |
|
COLLEGIUM PHARMACEUTICAL, INC. | -2.9% |
|
GILEAD SCIENCES INC | -2.8% |
|
CATALYST PHARMACEUTICAL PART | -2.7% |
|
NATERA INC | -2.5% |
|
AMGEN INC | -2.5% |
|
NEUROCRINE BIOSCIENCES INC | -2.4% |
|
BIOGEN IDEC INC | -2.3% |